Middle East & Africa Malaria Treatment Market to 2032
Overview
The Middle East & Africa Malaria Treatment Market is expected to reach a 1,041.67 USD Million by 2032 and is projected to grow at a CAGR of 9.89% from 2025 to 2032.
Revenue, 2024 (USD Million)
641.67
Forecast, 2032 (USD Million)
1,041.67
CAGR, 2024 - 2032
9.89%
Report Coverage
Middle East & Africa
Middle East & Africa Malaria Treatment Market 2018-2032 USD Million
Middle East & Africa Malaria Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 641.67 USD Million
- Projected Market Size (2032): 1,041.67 USD Million
- CAGR (2025-2032): 9.89%
Key Findings of Middle East & Africa Malaria Treatment Market
- The Middle East & Africa Malaria Treatment Market was valued at 1,041.67 USD Million in 2024.
- The Middle East & Africa Malaria Treatment Market is likely to grow at a CAGR of 9.89% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Medication in Type Segment accounted for the largest share of the market with a revenue of 605.57 USD Million
- The fastest growing segment Vaccine in Type Segment grew Fastest with a CAGR of 43.41% during the forecast period from 2024 to 2032.
Middle East & Africa Malaria Treatment Market Scope
Middle East & Africa Malaria Treatment Market Segmentation & Scope
Agent
- P. KNOWLELSI
- P. MALARIAE
- P. VIVAX
- P. OVALE
- PLASMODIUM FALCIPARUM
Type
- Vaccine
- Medication
Route of Administration
- Parenteral
- Oral
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospitals
Drug Type
- Branded
- Generics
Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- Direct Tender
Treatment Type
- Radical Treatment
- Suppressive Treatment
Middle East & Africa Malaria Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 641.67 USD Million |
| Market Value in 2032 | 1,041.67 USD Million |
| CAGR (2025-2032) | 9.89% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Agent, Type, Route of Administration, End User, Drug Type, Distribution Channel, Treatment Type |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 641.67 USD Million in 2024
- Key Country: Nigeria, leading in terms of revenue with value of 217.03 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Malaria Treatment Market to 2032, By Agent
- PLASMODIUM FALCIPARUM is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 528.86 USD Million in the year 2024.
- PLASMODIUM FALCIPARUM is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 10.37 % in forecast period 2025-2032.
-
Middle East & Africa Malaria Treatment Market to 2032, By Type
- Medication is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 605.57 USD Million in the year 2024.
- Vaccine is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 8.29 % in forecast period 2025-2032.
-
Middle East & Africa Malaria Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 499.43 USD Million in the year 2024.
- Oral is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 10.48 % in forecast period 2025-2032.
-
Middle East & Africa Malaria Treatment Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 398.37 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 10.80 % in forecast period 2025-2032.
-
Middle East & Africa Malaria Treatment Market to 2032, By Drug Type
- Generics is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 488.61 USD Million in the year 2024.
- Generics is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 10.22 % in forecast period 2025-2032.
-
Middle East & Africa Malaria Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 414.86 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 11.41 % in forecast period 2025-2032.
-
Middle East & Africa Malaria Treatment Market to 2032, By Treatment Type
- Suppressive Treatment is the largest segment in Middle East & Africa Malaria Treatment Market to 2032 with a revenue of 570.33 USD Million in the year 2024.
- Suppressive Treatment is the Fastest growing segment in Middle East & Africa Malaria Treatment Market to 2032 with a Growth rate of 10.06 % in forecast period 2025-2032.
Middle East & Africa Malaria Treatment Market Company Share Analysis
Middle East & Africa Malaria Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Malaria Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Malaria Treatment Market is segmented based on Segmentation Agent, Type, Route of Administration, End User, Drug Type, Distribution Channel, Treatment Type.
Middle East & Africa Malaria Treatment Market was valued at USD 641.67(Revenue in USD Million) in 2020.
Middle East & Africa Malaria Treatment Market is projected to grow at a CAGR of 9.89% during the forecast period of 2024 to 2032.
The Medication segment is expected to dominate the Middle East & Africa Malaria Treatment Market, holding a largest market share of 605.57 USD Million in 2024
Middle East & Africa Malaria Treatment Market Scope
Middle East & Africa Malaria Treatment Market Segmentation & Scope
Agent
- P. KNOWLELSI
- P. MALARIAE
- P. VIVAX
- P. OVALE
- PLASMODIUM FALCIPARUM
Type
- Vaccine
- Medication
Route of Administration
- Parenteral
- Oral
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospitals
Drug Type
- Branded
- Generics
Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- Direct Tender
Treatment Type
- Radical Treatment
- Suppressive Treatment
Frequently Asked Questions
The Middle East & Africa Malaria Treatment Market is segmented based on Segmentation Agent, Type, Route of Administration, End User, Drug Type, Distribution Channel, Treatment Type.
Middle East & Africa Malaria Treatment Market was valued at USD 641.67(Revenue in USD Million) in 2020.
Middle East & Africa Malaria Treatment Market is projected to grow at a CAGR of 9.89% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Malaria Treatment Market for final year is USD 1,041.67 (USD Million).
Middle East & Africa Malaria Treatment Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Malaria Treatment Market is segmented based on Segmentation Agent, Type, Route of Administration, End User, Drug Type, Distribution Channel, Treatment Type.
Middle East & Africa Malaria Treatment Market was valued at USD 641.67(Revenue in USD Million) in 2020.
Middle East & Africa Malaria Treatment Market is projected to grow at a CAGR of 9.89% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Malaria Treatment Market for final year is USD 1,041.67 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.